Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Aug 15 2005
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it was granted a U.S. patent that covers the methods and compositions for the preservation of cells, tissues or organs in the...
- May 18 2005Orders to Commence in Second Quarter
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has entered into an exclusive manufacturing and distribution agreement with VWR International, a leader in the global research...
- Mar 04 2004
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today the settlement of a dispute between the Company and Irvine, CA-based Endocare, Inc. , arising out of Endocare's failure to register...
- Dec 03 2003$1.38 Million in Financing; $177,000 from NIH; $1.6 Million Awarded in Court Decision
BioLife Solutions Inc. (BULLETIN BOARD: BLFS) announced today that it has secured $1.381 million through the sale in a private placement to investors, of Units consisting of Series G Convertible...
- Mar 03 2003
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has signed a multi-year research and development agreement with Edison, NJ-based Tissue Transformation Technologies...